Human Immune Repertoire in Hepatitis B Virus Infection
Overview
Affiliations
Hepatitis B virus (HBV) infection is a public health threat that affects 257 million people worldwide and can progress to liver cirrhosis, liver failure, and hepatocellular carcinoma. The HBV antigen- induced adaptive immune response plays an important role in HBV clearance. Immune repertoire sequencing (IRS) has been used to investigate the molecular mechanisms behind the immune system, find novel ways to treat HBV infection, and evaluate the genetic responses and immune characteristics of individuals infected by HBV or immunized by HBV vaccine. This review summarizes the human immune repertoire analysis methodology, and the application of the IRS in the prediction of HBV infection progression, treatment, and vaccination.
Hu Y, Huang J, Wang S, Sun X, Wang X, Yu H Inflammation. 2024; .
PMID: 38914737 DOI: 10.1007/s10753-024-02079-2.
Xu R, Wu Y, Xiang X, Lv X, He M, Xu C Virus Res. 2024; 341:199316.
PMID: 38215982 PMC: 10825640. DOI: 10.1016/j.virusres.2024.199316.
T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer.
Mazzotti L, Gaimari A, Bravaccini S, Maltoni R, Cerchione C, Juan M Int J Mol Sci. 2022; 23(15).
PMID: 35955721 PMC: 9369427. DOI: 10.3390/ijms23158590.
Zhan Q, Chang L, Wu J, Zhang Z, Xu J, Yu Y Pathogens. 2022; 11(7).
PMID: 35889974 PMC: 9318409. DOI: 10.3390/pathogens11070727.
Yang J, Li Y, Ye J, Wang J, Lu H, Yao X J Inflamm Res. 2022; 15:939-951.
PMID: 35210805 PMC: 8856041. DOI: 10.2147/JIR.S347702.